Our clinical laboratory offers the Advanta™ Dx SARS-CoV-2 RT-PCR test enabling reliable, rapid, high-capacity testing of SARS-Cov-2 from easy to collect saliva samples.
The evolving COVID-19 pandemic continues to negatively impact organizations across the USA. Access to affordable, accurate and reliable COVID-19 testing remains essential.
Our team can help design and implement a testing program aligned with the unique requirements of your organization.
Sirona Dx is committed to helping organizations large and small respond to the COVID-19 outbreak, to protect workforces, customers, students and guests with our premium PCR-based COVID-19 saliva test.
Assisting Healthcare Staff Protect Themselves and their Patients
Facilitating the Safe Return to the Office and Classroom
Helping Sports Teams Continue to Safely Train and Compete
Keeping Guests and Travelers Moving
Ensuring Production Crews Continue to Film and Record
Helping Fans Enjoy Live Events
The expansion of workplace testing will identify more positive cases of COVID-19 and ensure those infected isolate. This will reduce the spread of the virus and protect those who cannot work from home including essential frontline workers.
Approximately 1 in 3 people who are infected with COVID-19 have no symptoms meaning they can spread the disease without knowing it. Broadening testing to identify those showing no symptoms will mean finding positive cases more quickly, and break chains of transmission.
Increased surveillance testing will reduce the risk of transmission among those who cannot work from home and ensure important public and economic services can continue.
Testing can provide confidence to workers and customers in the workplace, helping to protect and enable business continuity.
Antigen tests, though rapid, detect only small pieces of the virus and cannot make more copies of the targets they are designed to detect. Sensitivity is therefore limited by the original amount of target material present within the sample. By comparison, the PCR process targets viral genome segments that can be readily amplified to boost sensitivity. For this reason, molecular PCR testing methods outperform antigen testing in terms of sensitivity and the CDC calls the molecular test the "gold standard" for clinical diagnostic detection of SARS-CoV-2.
As antigen tests are less sensitive than most PCR-based tests, they have a higher false negative rate. For this reason, according to FDA guidance, if you test negative with an antigen test, a molecular test may be prescribed by your health care provider to confirm the result.
We provide test results within 24h of sample acquisition at our laboratory in Portland, Oregon. Please contact us to discuss logistics based on your location.
Our testing service launched in February 2021 after completion of a thorough clinical validation process. Our first clients were professional sports teams across the USA and today we support a diverse range of organizations providing reliable surveillance screening for SARS-Cov-2.